Group 1 - The former president of the company, Guan Yi, has resigned from the position of general manager due to personal reasons but will continue to serve as a director and hold relevant positions in the company's subsidiaries [2] - The company has experienced significant growth in revenue and net profit from 2021 to 2023, achieving double-digit year-on-year growth for three consecutive years [2] - However, the company has projected a net loss of approximately 240 million to 380 million yuan for the fiscal year 2025, representing a decline of 177.23% to 148.78% compared to the previous year [2] Group 2 - The company plans to enhance its management team by appointing experienced and influential professionals to operate in specialized lines [3] - There will be a continued investment in the health sector, leveraging the "Little Sunflower" brand to establish an "online-first + all-channel coverage" operational system [3] - The new management team members possess extensive industry experience and are well-aligned with the company's culture and operational model, which is expected to facilitate the implementation of the company's strategy and promote healthy and stable development [3]

Core Viewpoint - The company emphasizes that the healthcare sector is a core focus in its future health ecosystem layout, with a strategic push across three main segments: prescription pharmaceuticals, OTC pharmaceuticals, and the health and wellness sector [1] Group 1: Strategic Focus - The company plans to leverage its "Little Sunflower" brand advantage to build an "online-first + full-channel coverage" operational system [1] - The company will allocate experienced, professional, and influential management personnel to operate each segment independently [1] Group 2: Resource Investment - The company intends to continuously increase resource investment in the health and wellness sector [1] - A specialized marketing team will be central to the company's efforts in strengthening its market presence [1]

Group 1 - The core focus of the company is the healthcare sector, which is a key part of its future health ecosystem layout [1] - The company plans to increase resource investment in the health sector, leveraging the "Little Sunflower" brand advantage [1] - The operational system will be built on an "online-first + full-channel coverage" model, supported by a professional marketing team [1]